Quantifying Regulatory Bottlenecks in South Korea’s Clinical Trial Approval Process Through an Analytic Hierarchy Process Framework

  • Quan, Riyan; 
  • Purja, Sujata; 
  • Kim, Jonghyeok; 
  • Septanadhira, Karunia Ayu; 
  • Kim, Eunyoung
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Purpose: Drug lag is a critical issue limiting South Korea’s pharmaceutical competitiveness and patient access, and it has been linked to delays in the Investigational New Drug (IND) review process. This study aimed to identify key barriers affecting IND review efficiency in South Korea by analyzing real-world industry experience and to propose concrete strategic actions to mitigate drug lag. Methods: We employed an exploratory sequential mixed-methods design. First, we used grounded theory to identify problematic factors within the IND process through semi-structured interviews. We then applied the Analytic Hierarchy Process to evaluate these factors, followed by a quadrant analysis of importance and urgency to identify top-priority tasks. Results: Three core categories (rationality and patient-centricity, professional review, and operational efficiency), were identified as key domains for enhancing IND efficiency. Rationality and patient-centricity emerged as the most important and urgent criterion, followed closely by professional review. Within rationality and patient-centricity, four sub-criteria placed in the first quadrant (highly important and highly urgent): integration of patient needs into evaluation, global regulatory harmonization, acceptance of scientific evidence for new modalities, and adoption of overseas regulatory standards. Two sub-criteria within professional review (expert team review and standardized review guidelines) were also pinpointed in the first quadrant. Although operational efficiency ranked lowest, simplified Korean translation requirements stood out as the most critical factor within this category. Conclusion: Transitioning from focusing on procedural speed toward embracing regulatory flexibility to enhance scientific rationality and patient access is a viable pathway for mitigating drug lag in South Korea.

키워드

Analytic hierarchy process; Drug lag; Investigational new drug; Quadrant analysis
제목
Quantifying Regulatory Bottlenecks in South Korea’s Clinical Trial Approval Process Through an Analytic Hierarchy Process Framework
저자
Quan, Riyan; Purja, Sujata; Kim, Jonghyeok; Septanadhira, Karunia Ayu; Kim, Eunyoung
DOI
10.1007/s12247-026-11064-1
발행일
2027-02
유형
Article
저널명
Journal of Pharmaceutical Innovation
권
22
호
1